Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06301867 · ClinicalTrials.gov registry record
Preventing Failed Extubations
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 248
- Enrollment target
NCT06301867: Completed study, sponsored by Duke University.
NCT06301867 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06301867 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
More than 300,00 people in the United States experience acute respiratory failure and require mechanical ventilation every year. Of those that recover and are extubated, the most common reason for reintubation is recurrent respiratory failure. Our study proposes a novel methodology for identifying those patients most at risk for recurrent respiratory failure.
Primary Outcome
Feasibility is defined as 95% of patients having had a plateau pressure measured prior to extubation.
Interventions
- DIAGNOSTIC_TEST Plateau Pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-11-05 |
What the finished NCT06301867 record still lists
NCT06301867 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Plateau Pressure is the first listed.
NCT06301867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06301867 about?
NCT06301867 is a clinical study titled "Preventing Failed Extubations". More than 300,00 people in the United States experience acute respiratory failure and require mechanical ventilation every year. Of those that recover and are extubated, the most common reason for reintubation is recurrent respiratory failure. Our study proposes a novel methodology for identifying t...
What is the current status of trial NCT06301867?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2024-03-01. Estimated completion is 2024-11-05.
What interventions are being tested in trial NCT06301867?
The interventions under investigation include: Plateau Pressure (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06301867?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI